[1]
H. Yang, “Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplantation: a two year prospective cohort study”, J Pharm Pharm Sci, vol. 24, pp. 220–226, May 2021.